These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7532235)

  • 1. Symptoms and urodynamics.
    Mebust WK
    J Urol; 1995 Mar; 153(3 Pt 1):694. PubMed ID: 7532235
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of urodynamic study in the evaluation and management of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    Gerber GS
    Urology; 1996 Nov; 48(5):668-75. PubMed ID: 8911507
    [No Abstract]   [Full Text] [Related]  

  • 3. In support of pressure-flow studies for evaluating men with lower urinary tract symptoms.
    Abrams P
    Urology; 1994 Aug; 44(2):153-5. PubMed ID: 7519378
    [No Abstract]   [Full Text] [Related]  

  • 4. Multichannel urodynamic studies in men with benign prostatic hyperplasia. Indications and interpretation.
    Blaivas JG
    Urol Clin North Am; 1990 Aug; 17(3):543-52. PubMed ID: 1695781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Objective evaluation of bladder outlet obstruction.
    Abrams P
    Br J Urol; 1995 Jul; 76 Suppl 1():11-5. PubMed ID: 7544210
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of urodynamic investigation in the assessment of benign prostatic hypertrophy.
    McGuire EJ
    J Urol; 1992 Oct; 148(4):1133-6. PubMed ID: 1383572
    [No Abstract]   [Full Text] [Related]  

  • 7. Why pressure-flow studies should be optional and not mandatory studies for evaluating men with benign prostatic hyperplasia.
    McConnell JD
    Urology; 1994 Aug; 44(2):156-8. PubMed ID: 7519379
    [No Abstract]   [Full Text] [Related]  

  • 8. [Correlation of the factors on benign prostatic hyperplasia combined with obstruction].
    Chen Q; Wang YX
    Zhonghua Nan Ke Xue; 2002; 8(4):299-301. PubMed ID: 12491701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial comment on: Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up.
    Bachmann A
    Eur Urol; 2008 Oct; 54(4):908-9. PubMed ID: 18502568
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial comment on: Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up.
    Reich O
    Eur Urol; 2008 Oct; 54(4):908. PubMed ID: 18502566
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial comment on: Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up.
    Seitz M
    Eur Urol; 2008 Oct; 54(4):909-10. PubMed ID: 18502567
    [No Abstract]   [Full Text] [Related]  

  • 12. The correlation between bladder outlet obstruction and lower urinary tract symptoms as measured by the international prostate symptom score.
    el Din KE; Kiemeney LA; de Wildt MJ; Rosier PF; Debruyne FM; de la Rosette JJ
    J Urol; 1996 Sep; 156(3):1020-5. PubMed ID: 8709300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Residual fraction in the evaluation of bladder outlet obstruction resulting from benign prostatic hyperplasia].
    Cheng W; Gao JP; Zhang ZY; Ge JP; Xue S
    Zhonghua Nan Ke Xue; 2003; 9(4):273-4. PubMed ID: 12931369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial comment on: plasma vaporisation of the prostate: initial clinical results.
    Ahyai SA
    Eur Urol; 2010 Apr; 57(4):697-8. PubMed ID: 19482413
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of maximum detrusor contraction power in relation to bladder emptying in patients with lower urinary tract symptoms and benign prostatic enlargement.
    Rosier PF; de Wildt MJ; de la Rosette JJ; Debruyne FM; Wijkstra H
    J Urol; 1995 Dec; 154(6):2137-42. PubMed ID: 7500477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urodynamics in benign prostatic hyperplasia (BPH).
    Schäfer W
    Arch Ital Urol Androl; 1993 Dec; 65(6):599-613. PubMed ID: 7508790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience in lower urinary tract symptoms.
    Kakizaki H; Machino R; Koyanagi T
    BJU Int; 2001 Sep; 88 Suppl 2():23-6; discussion 49-50. PubMed ID: 11589666
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of invasive urodynamic testing in benign prostatic hyperplasia and male lower urinary tract symptoms.
    Mehdizadeh JL; Leach GE
    Urol Clin North Am; 2009 Nov; 36(4):431-41, v. PubMed ID: 19942043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of residual urine volume in bladder outlet obstruction with benign prostatic hyperplasia].
    Wu Z; Wu K; Wang B
    Zhonghua Wai Ke Za Zhi; 1997 Jun; 35(6):374-6. PubMed ID: 10374477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceleration of flow rate in obstructive detrusor instability.
    Cucchi A
    Br J Urol; 1990 Jul; 66(1):26-9. PubMed ID: 1697489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.